GILDGilead
Pharma & Healthcare · US · Gilead Sciences, Inc.
6 of 6 ratios computed · receipts verified server-side
The full receipt
Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.
- Markup →
How much revenue per dollar of cost.
4.1365× revenue / costverified$1 of cost becomes $4.14 of revenueSector median: 3.1882Top 23% for extraction in sectorFY 2023v1.0.0 - Operational Markup →
Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.
1.5704× revenue / (cost + opex)verified$1 of cost+opex becomes $1.57 of revenueSector median: 1.2871Top 12% for extraction in sectorFY 2023v1.0.0 - Labor Share →
How much of every revenue dollar reaches workers.
0.1780of revenue → workersapprox.verified18¢ of every $1 of revenue reaches workersSector median: 0.1761Median range for extraction in sectorFY 2023v1.0.0 - Executive Extraction →
How many times a CEO out-earns the median employee.
109.8× CEO / median workerverifiedCEO earns 110× the median workerSector median: 263.0Bottom 16% for extraction in sectorFY 2023v1.0.0 - Shareholder Extraction →
Dollars sent to shareholders for every dollar invested in R&D.
0.9022× buybacks+dividends / R&Dverified$0.90 to shareholders per $1 in R&D — net reinvestingSector median: 0.7492Median range for extraction in sectorFY 2023v1.0.0 - Capital Extraction →
How much of net profit goes to shareholders rather than back into the business.
0.6668× buybacks+dividends / net incomeverified67% of net profit returned to shareholders, 33% reinvestedSector median: 0.5294Median range for extraction in sectorFY 2023v1.0.0
Company response
No verified response yet. If you represent Gilead, you can add context, agree, or dispute.
Source data
Every raw line item this company disclosed in its XBRL filings. Click any filing to view the original on SEC.gov.
| Concept | Value | Unit | Period | Filing | Receipt |
|---|---|---|---|---|---|
CEO Total Compensation CEOTotalCompensation | 22,607,690 | USD | FY | 0001308179-24-000348 | verified |
Cost of Goods Sold CostOfGoodsAndServicesSold | 6,601,000,000 | USD | FY | 0000882095-24-000007 | verified |
Dividends Paid PaymentsOfDividends | 3,605,000,000 | USD | FY | 0000882095-24-000007 | verified |
Median Employee Compensation MedianEmployeeCompensation | 205,866 | USD | FY | 0001308179-24-000348 | verified |
Net Income NetIncomeLoss | 6,225,000,000 | USD | FY | 0000882095-24-000007 | verified |
Operating Expenses OperatingExpensesDerived(CostsAndExpenses-COGS) | 10,786,000,000 | USD | FY | 0000882095-24-000007 | verified |
R&D Expense ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | 4,601,000,000 | USD | FY | 0000882095-24-000007 | verified |
Revenue RevenueFromContractWithCustomerExcludingAssessedTax | 27,305,000,000 | USD | FY | 0000882095-24-000007 | verified |
Stock Buybacks PaymentsForRepurchaseOfCommonStock | 546,000,000 | USD | FY | 0000882095-24-000007 | verified |
Total Employee Count TotalEmployees | 18,157 | employees | FY | 0001308179-24-000348 | verified |